Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
Background: Although many acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients have been treated with hypomethylating agents (HMAs) as a substitute for intensive chemotherapy in recent years, the incidence of invasive fungal infections (IFIs) and the efficacy of posaconazole as a...
Main Authors: | Ka-Won Kang, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/2040620720966882 |
Similar Items
-
THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: G. A. Klyasova, et al.
Published: (2017-11-01) -
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01) -
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Kah Keng Wong, et al.
Published: (2021-02-01) -
Predictors of Febrile Neutropenia and Role of Levofloxacin Prophylaxis in Acute Myeloid Leukemia And High-Risk Myelodysplastic Syndrome Patients Treated With Hypomethylating Agents
by: A. Fiorentini, et al.
Published: (2020-09-01) -
Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
by: Elif Gulsum Umit, et al.
Published: (2020-05-01)